Caffeine: traditional and new therapeutic indications and use as a dermatological model drug

被引:3
|
作者
Bors Luca [1 ]
Bajza Agnes [1 ]
Kocsis Dorottya [1 ]
Erdo Franciska [1 ]
机构
[1] Pazmany Peter Katolikus Egyet, Informacios Technol & Bionikai Kar, Budapest, Hungary
关键词
caffeine; melanoma; dermatology; cosmetology; hepatoprotection; CUTANEOUS MALIGNANT-MELANOMA; COFFEE CONSUMPTION; IN-VITRO; DISEASE; RISK; METAANALYSIS; MECHANISMS; CELLULITE; HEALTH; WOMEN;
D O I
10.1556/650.2018.30993
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coffee consumption had already been described in the 15th century. The spreading of coffee drinking was not only a consequence of its delicious aromatic taste, but also of its pharmacological effects, especially due to its caffeine content. In this review, the mechanisms behind its complex stimulatory effects and the latest studies on the possible new therapeutic indications of caffeine are summarized. Several papers reported the neuroprotective ( in Alzheimer's and Parkinson's disease) and hepatoprotective profiles of caffeine, and we show the most promising new results about its preventive properties in dermal malignancies. These findings were described both in cell cultures and in vivo. The application of caffeine and coffee in cosmetology and dermatological products is based on their antioxidant property and on the above-mentioned beneficial effects. Caffeine is also presented here as a dermatological model drug due to its hydrophilic profile. It can be used for designing and comparing different novel drug formulations, although beside the transcellular route, the follicular and transappendageal pathways play also important roles in its skin penetration. Taken together, caffeine molecule has many recently discovered beneficial pharmacological effects, but one should be careful with its excessive consumption. It can result in several adverse events if overdosed and in case of regular intake of high doses, after abandonment, withdrawal symptoms may appear.
引用
收藏
页码:384 / 390
页数:7
相关论文
共 50 条
  • [1] Use of thalidomide in dermatological indications
    Kontogiannis, V
    Powell, RJ
    [J]. BIODRUGS, 2000, 13 (04) : 255 - 265
  • [2] Use of Thalidomide in Dermatological Indications
    Vlassis Kontogiannis
    Richard J. Powell
    [J]. BioDrugs, 2000, 13 : 255 - 265
  • [3] New indications for the use of therapeutic hypothermia
    Bernard, S
    [J]. CRITICAL CARE, 2004, 8 (06):
  • [4] New indications for the use of therapeutic hypothermia
    Stephen Bernard
    [J]. Critical Care, 8
  • [5] Use of saliva in therapeutic drug monitoring of caffeine in preterm infants
    de Wildt, SN
    Kerkvliet, KTM
    Wezenberg, MGA
    Ottink, S
    Hop, WCJ
    Vulto, AG
    van den Anker, JN
    [J]. THERAPEUTIC DRUG MONITORING, 2001, 23 (03) : 250 - 254
  • [6] Dermatological indications for the use of isotretinoin beyond acne
    Forbat, Emily
    Ali, Faisal R.
    Al-Niaimi, Firas
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (07) : 698 - 705
  • [7] Drug repositioning: Re-investigating existing drugs for new therapeutic indications
    Padhy, B. M.
    Gupta, Y. K.
    [J]. JOURNAL OF POSTGRADUATE MEDICINE, 2011, 57 (02) : 153 - 160
  • [8] ZINC AS NEW THERAPEUTIC AGENT FOR DERMATOLOGICAL DISORDERS
    BRAUNFALCO, O
    [J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1977, 119 (02): : 7 - 8
  • [9] On extending the indications for the use of therapeutic hypothermia
    Nilsson, Fredrik
    Hoglund, Peter
    Nielsen, Niklas
    [J]. CRITICAL CARE MEDICINE, 2009, 37 (10) : 2865 - 2865
  • [10] Formalizing drug indications on the road to therapeutic intent
    Nelson, Stuart J.
    Oprea, Tudor I.
    Ursu, Oleg
    Bologa, Cristian G.
    Zaveri, Amrapali
    Holmes, Jayme
    Yang, Jeremy J.
    Mathias, Stephen L.
    Mani, Subramani
    Tuttle, Mark S.
    Dumontier, Michel
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2017, 24 (06) : 1169 - 1172